Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-05-28Clinical Trial Update: Immunotherapy Combined With Radiation and Influenza Vaccine for Pancreatic Cancer. [Phase 2]
A Phase 2 trial evaluating immunotherapy combined with radiation and an influenza vaccine for pancreatic cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2024-05-22Clinical Trial Update: QUILT-3.070:Pancreatic Cancer Vaccine: Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy [Phase 1, Phase 2]
Phase 1/2 pancreatic cancer vaccine QUILT-3.070 from ImmunityBio was terminated with results posted in May 2024.
-
CLINICAL_TRIALS trial_result · 2024-05-21Clinical Trial Update: Blue and Amber Light Exposure in Patients With Rectal and Pancreatic Cancer [NA]
This clinical trial update notes termination of a study evaluating blue and amber light exposure in patients with pancreatic and rectal canc…
-
CLINICAL_TRIALS trial_result · 2024-05-21Clinical Trial Update: Phase 2b Study of GC4711 in Combination With SBRT for Nonmetastatic Pancreatic Cancer [Phase 2]
A Phase 2b trial evaluating GC4711 in combination with SBRT for nonmetastatic pancreatic cancer was terminated, with results posted in May 2…
-
CLINICAL_TRIALS trial_result · 2024-05-14Clinical Trial Update: Role of CTC´s Spread During Pancreaticoduodenectomy in Patients With Pancreatic and Periampullary Tumors [NA]
This clinical trial update reports on the role of circulating tumor cells spread during pancreaticoduodenectomy in patients with pancreatic …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-05-09Clinical Trial Update: A Study of Penpulimab and Anlotinib Plus Nab-paclitaxel and Gemcitabine for Metastatic Pancreatic Cancer. [Phase 2]
Phase 2 trial evaluating Penpulimab and Anlotinib with Nab-paclitaxel and Gemcitabine in metastatic pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2024-05-08Clinical Trial Update: Nimotuzumab Plus AG in Pancreatic Cancer With Liver Metastasis [Phase 2]
A Phase 2 clinical trial is evaluating Nimotuzumab in combination with AG for pancreatic cancer with liver metastasis; the current status is…
-
CLINICAL_TRIALS trial_result · 2024-05-07Clinical Trial Update: Failure to Adjuvant Therapy After Pancreatic Resection for Pancreatic Cancer
A completed clinical trial update describing the absence or lack of adjuvant therapy following pancreatic cancer resection.
-
CLINICAL_TRIALS trial_result · 2024-05-07Clinical Trial Update: Evaluation of Nutritional Scores as Predictive Factors of Postoperative Outcome After Pancreatic Surgery
Completed clinical trial evaluating whether nutritional scores can predict postoperative outcomes after pancreatic surgery.
-
CLINICAL_TRIALS trial_result · 2024-05-03Clinical Trial Update: 89Zr-MMOT PET Imaging in Pancreatic and Ovarian Cancer Patients [Phase 1]
Phase 1 clinical trial evaluating 89Zr-MMOT PET imaging in pancreatic and ovarian cancer patients has completed.
-
CLINICAL_TRIALS trial_result · 2024-05-02Clinical Trial Update: High Dose Vitamin C Intravenous Infusion in Patients With Resectable or Metastatic Solid Tumor Malignancies [Phase 2]
Phase 2 trial evaluating high-dose intravenous vitamin C in patients with resectable or metastatic solid tumors has completed, with results …
-
CLINICAL_TRIALS trial_result · 2024-05-01Clinical Trial Update: Sequential AG and mFOLFOX Combined With Serplulimab Injection and Bevacizumab Injection in Untreated Advanced Pancreatic Cancer [Phase 2]
Phase 2 clinical trial evaluating sequential AG and mFOLFOX chemotherapy with serplulimab and bevacizumab in untreated advanced pancreatic c…
-
CLINICAL_TRIALS trial_result · 2024-04-25Clinical Trial Update: Phase 1/2 Study to Evaluate Safety, PK and Efficacy of the MYC-Inhibitor OMO-103 in Solid Tumours [Phase 1, Phase 2]
Phase 1/2 study evaluating the safety, pharmacokinetics, and efficacy of the MYC-inhibitor OMO-103 in solid tumors, including pancreatic and…
-
CLINICAL_TRIALS trial_result · 2024-04-24Clinical Trial Update: Saltikva for Metastatic Pancreatic Cancer [Phase 2]
Phase 2 clinical trial update for Saltikva in metastatic pancreatic cancer.
-
CLINICAL_TRIALS trial_result · 2024-04-19Clinical Trial Update: Neoadjuvant CCRT With Gemcitabine/Durvalumab (MEDI4736) Followed by Adjuvant Gemcitabine/Durvalumab(MEDI4736) in Resectable or Borderline Resectable Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating neoadjuvant chemoradiation with gemcitabine and durvalumab followed by adjuvant gemcitabine and durvalumab in resec…
-
CLINICAL_TRIALS trial_result · 2024-04-19Clinical Trial Update: Pembrolizumab Plus Chemotherapy in 1st Line Treatment of Pancreatic Cancer [Phase 2]
Phase 2 trial update evaluating pembrolizumab plus chemotherapy as first-line treatment for pancreatic cancer.
-
CLINICAL_TRIALS trial_result · 2024-04-18Clinical Trial Update: Analyzing Childhood Recall Antigens in Patients With Pancreatic Cancer [Phase 2]
Phase 2 clinical trial update for childhood recall antigens in patients with pancreatic cancer; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2024-04-17Clinical Trial Update: A Study of the Treatment of Disitamab Vedotin in Patients With Locally Advanced or Metastatic Pancreatic Cancer [Phase 2]
Phase 2 clinical trial update for disitamab vedotin in locally advanced or metastatic pancreatic cancer.
-
CLINICAL_TRIALS trial_result · 2024-04-11Clinical Trial Update: Pancreatic Carcinoma: Chemoradiation Compared With Chemotherapy Alone After Induction Chemotherapy [Phase 3]
A Phase 3 trial comparing chemoradiation versus chemotherapy alone after induction chemotherapy in pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2024-04-09Clinical Trial Update: Prophylactic Administration of Neulapeg (Pegteograstim) in Patients With Locally Advanced or Metastatic Pancreatic Cancer Receiving the Modified FOLFIRINOX [Phase 2]
Phase 2 trial evaluating prophylactic Neulapeg (Pegteograstim) in patients with locally advanced or metastatic pancreatic cancer receiving m…
-
CLINICAL_TRIALS trial_result · 2024-04-04Clinical Trial Update: A Study of Nimotuzumab Combinated With Gemcitabine in K-RAS Wild-type Locally Advanced and Metastatic Pancreatic Cancer [Phase 3]
Phase 3 trial investigating nimotuzumab with gemcitabine in K-RAS wild-type locally advanced or metastatic pancreatic cancer completed with …
-
CLINICAL_TRIALS trial_result · 2024-04-03Clinical Trial Update: A Study of GB201 in Combination With Weekly Paclitaxel and Low-dose Gemcitabine in Patients With Pancreatic Cancer [Phase 2, Phase 3]
Clinical trial update for GB201 in combination with weekly paclitaxel and low-dose gemcitabine in metastatic pancreatic cancer is currently …
-
CLINICAL_TRIALS trial_result · 2024-04-02Clinical Trial Update: A Prospective, Randomized, Double-blinded, Multi-center Clinical Trial to Evaluate the Efficiency and Safety of Anti-PD1 Antibody (Camrelizumab) Combined With Paclitaxel(Albumin Bound) and Gemcitabine as First-line Therapy in Patients With Metastatic Pancreatic Cancer [Phase 3]
A Phase 3 randomized trial evaluating camrelizumab with paclitaxel albumin-bound and gemcitabine as first-line therapy for metastatic pancre…
-
CLINICAL_TRIALS trial_result · 2024-03-29Clinical Trial Update: Dose Escalation Study MORAb-066 Targeting Tissue Factor (TF)-Expressing Malignancies Including Breast, Pancreatic, Colorectal, NSCLC [Phase 1]
Phase 1 dose-escalation study of MORAb-066 targeting tissue factor-expressing malignancies, including breast, pancreatic, colorectal, and no…
-
CLINICAL_TRIALS trial_result · 2024-03-28Clinical Trial Update: A Study of Maintenance Treatment With Fluzoparib in gBRCA/PALB2 Mutated Pancreatic Cancer Whose Disease Has Not Progressed on First Line Platinum-Based Chemotherapy [Phase 3]
Phase 3 trial of maintenance Fluzoparib in gBRCA/PALB2-mutated metastatic pancreatic cancer terminated after first-line platinum therapy.